NCI CTEP Approved Trials for the Month of April

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month. For further information, contact the principal investigator listed.


Phase I

PBTC-042: Phase I Study of CDK 4-6 Inhibitor PD-0332991 in Children with Recurrent, Progressive or Refractory Central Nervous System Tumors. Pediatric Brain Tumor Consortium; Gururangan, Sridharan. (919) 668-6288


Phase I/II

ADVL1312: A Phase 1/2 Study of MK-1775 (AZD1775, IND# 121422) in Combination with Oral Irinotecan in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid Tumors. COG Phase 1 Consortium; Cole, Kristina Ann. (267) 426-2285

ADVL1411: A Phase 1/2 Study of BMN 673 (IND# 121510), an Oral Poly(ADP-Ribose) Polymerase Inhibitor, Plus Temozolomide in Children with Refractory or Recurrent Malignancies. COG Phase 1 Consortium; Schafer, Eric Stephen. (832) 825-4241

URCC-13070: Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers. University of Rochester; Mohile, Supriya Gupta. (585) 275-9319


Phase II

9416: A Randomized Phase II Trial of Cisplatin with or Without Wee1 Kinase Inhibitor MK-1775 for First-Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (RM-SCCHN). University Health Network-Princess Margaret Hospital; Winquist, Eric William. 519-685-6840


Phase III

E2112: A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer. ECOG-ACRIN Cancer Research Group; Connolly, Roisin M. (410) 614-9217


Other Phases

AALL14B4-Q: IRF-4, a Novel Tumor Suppressor in Pediatric BCR-ABL+ B-ALL. Children’s Oncology Group; Abrams, Scott. (716) 845-4375

AAML14B2-Q: Functional Proteomics for Stratification and Therapeutic Targeting of Chemotherapy Resistance in Acute Myeloid Leukemia. Children’s Oncology Group; Kentsis, Alex. (646) 888-2593

AAML14B3-Q: Targeting the STAT Pathway in Leukemia Stem Cells in Acute Myelogenous Leukemia. Children’s Oncology Group; Stevens, Alexandra Mclean. (832) 824-4824

ABTR13B1-Q: B-Lapachone as a Novel Targeted Therapy for Pediatric Cancers. Children’s Oncology Group; Laetsch, Theodore Willis. (214) 648-3896


Pilot Phase

ABTC-1302: Drug Distribution and Pharmacodynamic Study of Pulsatile Lapatinib in Surgically Accessible EGFR-Amplified Recurrent High-Grade Glioma. Adult Brain Tumor Consortium; Cloughesy, Timothy Francis. (310) 825-5321

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.

Login